Quality issue at US plant delays some Johnson & Johnson's vaccine
Apr 01, 2021
Maryland [US], April 1 : US pharmaceutical giant Johnson & Johnson has found a quality issue at a plant in Baltimore, Maryland helping manufacture its single-dose COVID-19 vaccine. The mix-up has said to have ruined as many as 15 million potential doses of vaccine.